Filing Details
- Accession Number:
- 0001209191-21-062728
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-03 16:55:44
- Reporting Period:
- 2021-11-01
- Accepted Time:
- 2021-11-03 16:55:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1658247 | Crinetics Pharmaceuticals Inc. | CRNX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1397266 | K Matthew Fust | C/O Crinetics Pharmaceuticals, Inc. 10222 Barnes Canyon Road, Bldg 2 San Diego CA 92121 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-11-01 | 8,954 | $1.91 | 21,490 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-11-01 | 8,954 | $25.50 | 12,536 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified stock option (Right to Buy) | Disposition | 2021-11-01 | 8,954 | $0.00 | 8,954 | $1.91 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 12,092 | 2028-03-16 | No | 4 | M | Direct |
Footnotes
- The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 30 days prior to the trading date.
- Stock option granted March 17, 2018 with one-third vesting on the first anniversary of the grant date and the remainder vesting in a series of twenty-four (24) successive equal monthly installments thereafter.
Billionaire Hedge Funds
